Delivery Order SPE2DB22D3004-SPE2DB24FPF63
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML medication. The contract has a potential value of $1,225.44 and a completion date of February 7, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this order, which is part of a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceuticals. The award, valued at $1,225.44, has a completion date of February 7, 2024. This delivery order is likely part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which has a potential value of up to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceuticals. The $2,042.64 award has a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) with DLA to deliver pharmaceutical products and medical supplies to military treatment facilities worldwide....
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceuticals. The $1,370.47 contract has a completion date of March 1, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025,...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical for the provision of 4563881637 NOVOLOG 100 UNIT/ML FLEXPEN 3ML. The contract has a potential value of $2,067.44 and a completion date of March 7, 2024. This award is not associated with a set-aside program. The contract is part of a larger indefinite delivery contract (IDC) awarded solely to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,225.44 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp to supply a range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $1,225.44 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver a comprehensive range of pharmaceutical products and medical supplies to military treatment...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $5,726.77 by the Defense Logistics Agency (DLA) for the provision of NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,225.44 firm fixed price delivery order to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceuticals. The contract has a potential value of $1,225.44 and a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not associated with any set-aside program. In addition to this specific award, Amerisourcebergen...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPF63Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML medication valued at $1,225.44 with a completion date of February 8, 2024. This delivery order is a part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This contract award does not utilize any set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 2/7/24 |